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Kikuchi-Fujimoto disease, also known as histiocytic necrotizing lymphadenitis, is a self-limiting, benign, and rare systemic
lymphadenitis with unknown etiology. The cardinal symptoms are fever, lymphadenopathy and night sweat; consequently, it is
ﬁrst necessary to rule out infectious, lymphoproliferative, and connective tissue diseases such as systemic lupus erythematosus.
Histology can allow diagnosis by demonstrating necrotizing histiocyte lymphadenitis. Disease, which has no speciﬁc treatment,
self-limitsitselfin1to6monthsclinically.However,non-steroidanti-inﬂammatoryagentscanbegivenforsymptomatictreatment
and there are reports using corticosteroids and antibiotics in complicated cases. This article concerns a 32-years-old female who
diagnosed Kikuchi-Fujimoto disease and treated with glucocorticoid.
1.Introduction
Histiocytic necrotizing lymphadenitis was ﬁrst described in
1972 by two independent Japanese pathologists, Kikuchi
and Fujimoto [1, 2]. The classic presentation is in young
women with painful cervical adenopathy and has been
referred to as Kikuchi-Fujimoto disease (KFD) since the
initial publications. In patients presenting with cervical
adenopathy, the diﬀerential diagnosis can be broad. Here, we
present the case of a young woman with KFD and review the
signiﬁcant features of this syndrome.
2.CaseReport
A 32-year-old woman presented to our outpatient clinic
with generalized pain, tender left cervical adenopathy, loss of
appetite, night sweats, and fever to 41◦C. Her recent history
indicated progressive painful bilateral neck adenopathy for
about two months. She had earlier presented to a local
otolaryngology clinic and was given broad-spectrum antibi-
otics for possible lymphadenitis. She had no improvement
and developed weight loss, and ultimately a biopsy was
performed. Pathologic examination showed diﬀuse necrosis
with no deﬁnite malignancy. Although the morphologic
ﬁndings showed necrotizing lymphadenitis suggestive of
KFD, the tissue specimen was limited, and neoplasia could
not be excluded.
Her past history included appendectomy, cholecystec-
tomy,hypertension,andlevothyroxineforgoiter.Onphysical
exam, she was afebrile, and there was bilateral tender
conﬂuent cervical adenopathy without organomegaly or
other signiﬁcant ﬁndings. Laboratory studies were negative
for toxoplasmosis, hepatitis B, hepatitis C, HIV, CMV,
VDRL, and Brucella agglutination, while EBV-IgM showed
a borderline positive result. Anti-dsDNA was within nor-
mal limits, while ANA, RF, angiotensin-converting enzyme,
and PPD were negative. C-reactive protein (CRP) was
23.3mg/L, and the erythrocyte sedimentation rate (ESR)
was 69mm/hr. Routine biochemical analysis, coagulation
tests, and urinalysis were within normal limits. Peripheral
smear showed a relative lymphocytosis. CT-neck showed
bilateral cervical, submandibular, and left supraclavicular2 Case Reports in Medicine
Figure1:Apalestaining,irregularareaconsistsofminimalnecrosis
surrounded by a wide zone of immunoblasts and histiocytes (H&E,
×10).
Figure 2: Necrotic area devoid of polymorphonuclear leukocytes
but contains karyorrhectic debris (H&E, ×40).
lymphadenopathy, while CT-thorax and abdomen showed
no pathologic ﬁndings.
With the potential diagnosis of KFD, nonsteroidal
anti-inﬂammatory drug (NSAID) therapy with meloxi-
cam and diclofenac was given along with ciproﬂoxacin.
She had persistent fever and received additional antibi-
otics, blood cultures eventually grew methicillin-resistant
coagulase-negative Staphylococcus, and teicoplanin therapy
was started. Repeat cervical node excision was performed,
revealing lymphadenitis with predominant histiocyte and
plasmacytoid-like lymphocytes along with necrotic debris.
This was felt to be consistent with KFD (Figures 1, 2,a n d
3).
During this period, there was no signiﬁcant improve-
ment in her clinical course, despite antibiotic and NSAID
therapy, so methylprednisolone at 56mg/day (1mg/kg) was
started. She received this dose for 8 days, and then the
dose was tapered 8mg in every consecutive three days. Her
temperature returned to normal. Following the regulation
of corticosteroid treatment (8mg/day, po), the patient
was scheduled for close followup and discharged. At next
followup in one month, lymphocytosis had regressed; CRP
and ESR had returned to the normal range, and cervical
adenopathy was decreased by about 50%. Two months later,
physical examination and laboratory measurements were
Figure 3: Numerous CD68 histiocytes surrounding the areas
consist of karyorrhectic debris (H&E, ×10).
within normal limits, and it was decided to discontinue cor-
ticosteroid therapy (8mg/day, po). The patient is currently
notreceivinganytreatmentafter3monthsoffollowupandis
undergoing further assessment for possible connective tissue
disorder.
3. Discussion
KFD is a syndrome of unknown etiology. It is generally asso-
ciatedwithfever,sweats,andprogressivepainfuladenopathy,
primarily in the cervical region. The disease is rare, and most
reports are from the Asian countries, especially Japan [3].
Most patients are under the age of 30, with a female-to-male
ratio of 4:1 [4].
Therearemanyspeculationsastoetiologywithbothviral
and autoimmune processes suspected. Human Herpesvirus
6, Human Herpesvirus 8, parvovirus B-19, and Epstein-
Barr virus have all been implicated. The presentation is
generally acute, with progression over a 2-3 week period.
In this time frame, painful cervical adenopathy dominates,
with generalized lymphadenopathy uncommon [4], and
fever sometimes exceeds 40◦C. Other symptoms include
night sweats, upper respiratory complaints, and weight
loss. Laboratory analyses generally reveal leucopenia with a
relative lymphocytosis.
The diagnosis depends on examination of an excisional
biopsy with characteristic histopathologic ﬁndings of KFD,
including paracortical areas of coagulative necrosis with
abundant karyorrhectic debris, distortion of the nodal
architecture, and large numbers of histiocytes at the margins
of necrotic areas [4]. Although uncommon, the diagnosis
of KFD should be considered in a diﬀerential diagnosis that
includes tuberculosis, connective tissue diseases such as SLE,
or lymphoproliferative disorders. Indeﬁnite clinical followup
of KFD has been suggested for emergence of SLE or other
connective tissue disorders.
The process is typically limited from one to six months
[4], with recurrence reported in 3-4% of patients [5].
Lymphadenopathy can resolve spontaneously. Following
deﬁnitive diagnosis, the essentials of treatment include
analgesia, antipyretics, and NSAID therapy. Although rare, ifCase Reports in Medicine 3
extracervical or extranodal disease is present, corticosteroid
treatment is recommended [4].
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